These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 29611475)
21. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Pérez-Tomás R Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030 [TBL] [Abstract][Full Text] [Related]
23. An update on RNA interference-mediated gene silencing in cancer therapy. Ren YJ; Zhang Y Expert Opin Biol Ther; 2014 Nov; 14(11):1581-92. PubMed ID: 25010067 [TBL] [Abstract][Full Text] [Related]
24. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? Adamska A; Falasca M World J Gastroenterol; 2018 Aug; 24(29):3222-3238. PubMed ID: 30090003 [TBL] [Abstract][Full Text] [Related]
25. Overcoming multiple drug resistance in lung cancer using siRNA targeted therapy. Naghizadeh S; Mohammadi A; Baradaran B; Mansoori B Gene; 2019 Sep; 714():143972. PubMed ID: 31301483 [TBL] [Abstract][Full Text] [Related]
26. Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo. Hu Y; Li S; Yang M; Yan C; Fan D; Zhou Y; Zhang Y; Yagüe E; Xiong D Breast Cancer Res Treat; 2014 Jan; 143(2):287-99. PubMed ID: 24337682 [TBL] [Abstract][Full Text] [Related]
28. [RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM]. Deng KX; Zhong L; Jiang MX; Wang PL; Chen Y Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):836-9. PubMed ID: 16412331 [TBL] [Abstract][Full Text] [Related]
29. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells. McIntosh K; Balch C; Tiwari AK Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192 [TBL] [Abstract][Full Text] [Related]
30. Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs. Lim MMK; Wee JWK; Soong JC; Chua D; Tan WR; Lizwan M; Li Y; Teo Z; Goh WWB; Zhu P; Tan NS Mol Cancer; 2018 Oct; 17(1):152. PubMed ID: 30342537 [TBL] [Abstract][Full Text] [Related]
31. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? Yu M; Ocana A; Tannock IF Cancer Metastasis Rev; 2013 Jun; 32(1-2):211-27. PubMed ID: 23093326 [TBL] [Abstract][Full Text] [Related]
32. [Transmembrane transporters ABCC - structure, function and role in multidrug resistance of cancer cells]. Dębska S; Owecka A; Czernek U; Szydłowska-Pazera K; Habib M; Potemski P Postepy Hig Med Dosw (Online); 2011 Aug; 65():552-61. PubMed ID: 21918258 [TBL] [Abstract][Full Text] [Related]
33. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Modok S; Mellor HR; Callaghan R Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355 [TBL] [Abstract][Full Text] [Related]
34. Expanding the repertoire of RNA interference screens for developing new anticancer drug targets. Haney SA Expert Opin Ther Targets; 2007 Nov; 11(11):1429-41. PubMed ID: 18028008 [TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo inhibition of MRP gene expression and reversal of multidrug resistance by siRNA. Wu Z; Li X; Zeng Y; Zhuang X; Shen H; Zhu H; Liu H; Xiao H Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):177-84. PubMed ID: 21073659 [TBL] [Abstract][Full Text] [Related]
36. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells. Alberti L; Losi L; Leyvraz S; Benhattar J PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996 [TBL] [Abstract][Full Text] [Related]
37. Reversing agents for ATP-binding cassette drug transporters. Lee CH Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930 [TBL] [Abstract][Full Text] [Related]
38. Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance. Videira M; Reis RL; Brito MA Biochim Biophys Acta; 2014 Dec; 1846(2):312-25. PubMed ID: 25080053 [TBL] [Abstract][Full Text] [Related]
39. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers. Blanchard Z; Paul BT; Craft B; ElShamy WM Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261 [TBL] [Abstract][Full Text] [Related]
40. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer. Glackin CA Enzymes; 2018; 44():83-101. PubMed ID: 30360816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]